| Literature DB >> 26198682 |
Gökhan Aksan1, Gökay Nar2, Sinan İnci2, Ahmet Yanık3, Kadriye Orta Kılıçkesmez1, Olcay Aksoy4, Korhan Soylu5.
Abstract
BACKGROUND: Although myocardial bridging (MB) is defined as an angiographic phenomenon with a benign course, it has also been associated with adverse cardiovascular events. The effects of exercise on myocardial repolarization in patients with MB were tested in this study, with Tp-e and Tp-e/QT repolarization indexes.Entities:
Mesh:
Year: 2015 PMID: 26198682 PMCID: PMC4515937 DOI: 10.12659/MSM.893632
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Diagram demonstrating ventricular repolarization parameters measured from surface ECG.
Baseline clinical and laboratory characteristics of study population and comparison between groups.
| Variable | MB group (n=50) | Control group (n=48) | P value |
|---|---|---|---|
| Age (years) | 48.2±9.8 | 49.1±8.4 | 0.610 |
| Male, n (%) | 21 (42) | 22 (46) | 0.702 |
| Body mass index (kg/m2) | 26.8±3.7 | 28.3±3.1 | 0.187 |
| Hypertension, n (%) | 17 (34) | 15 (31) | 0.772 |
| Smoking, n (%) | 18 (36) | 16 (33) | 0.782 |
| Hemoglobin (g/L) | 13.9±1.6 | 13.3±1.7 | 0.785 |
| White blood cell count, 103/mm3 | 7.19±1.78 | 6.89±1.54 | 0.383 |
| Platelet, 103/mm3 | 251.2±60.9 | 239.1±55.7 | 0.308 |
| Creatinine, mg/dL | 0.83±0.16 | 0.83±0.18 | 0.848 |
| Fasting glucose, mg/dL | 88.1±10.9 | 85.2±10.8 | 0.199 |
| Total cholesterol, mg/dL | 195.4±38 | 184.4±42.6 | 0.181 |
| Low-density lipoprotein cholesterol, mg/dL | 122.3±31.5 | 122.1±30.1 | 0.983 |
| High-density lipoprotein cholesterol, mg/dL | 42.8±7.4 | 45.5±9.5 | 0.118 |
| Triglyceride, mg/dL | 158.6±55.3 | 164.5±70.2 | 0.642 |
| AST, U/L | 21.8±12.5 | 23.8±11.9 | 0.432 |
| ALT, U/L | 20.7±11.5 | 20.1±10.9 | 0.822 |
| Na, mmol/L | 141.3±2.7 | 141.2±2.8 | 0.763 |
| K, mmol/L | 4.2±0.3 | 4.1±0.3 | 0.564 |
| Ca, mg/dL | 9.0±0.6 | 8.9±0.6 | 0.582 |
| TSH, uIU/mL | 2.3±1.0 | 2.5±1 | 0.355 |
| Hs-CRP (mg/L) | 1.1±0.5 | 1.0±0.3 | 0.856 |
| eGFR | 108.1±12.6 | 111.5±10.7 | 0.255 |
| Cardiovascular medication | |||
| ACE-I/ARB, n (%) | 12 (24) | 10 (20.8) | 0.108 |
| Beta-blocker | 11 (22) | 8 (16.6) | 0.195 |
| Calcium channel blocker, n (%) | 4 (8) | 5 (10.4) | 0.755 |
| Nitrate, n (%) | 3 (6) | 2 (4.1) | 0.169 |
| Statin, n (%) | 7 (14) | 5 (10.4) | 0.296 |
| Bridging segment characteristics | |||
| Length of MB (mm) | 15.3±4.5 | ||
| Percentage of diameter reduction (%) | 65.1±9.7 | ||
| Site of MB | |||
| LAD, n (%) | 47 (94) | ||
| LCX, n (%) | 2 (4) | ||
| RCA, n (%) | 1 (2) | ||
| Degree of narrowing | |||
| 50–74%, n (%) | 46 (92) | ||
| ≥75%, n (%) | 4 (8) | ||
AST – aspartate aminotransferase; ALT – alanine aminotransferase; TSH – thyroid-stimulating hormone; LAD – Left anterior descending artery; LCX – left circumflex coronary artery; RCA – right coronary artery; MB – myocardial bridge; Hs-CRP – high sensitive C-reactive protein; ACE-I – angiotensin converting enzyme inhibitor; ARB – angiotensin receptor blocker; GFR – glomerular filtration rate.
e-GFR was calculated based on the Cockcroft-Gault equation: estimated creatinine clearance = (140-age) × (weight in kg) × (0.85 if female)/72 × serum creatinine.
Conventional echocardiographic parameters.
| Variable | MB group (n=50) | Control group (n=48) | P value |
|---|---|---|---|
| LVEDD (mm) | 47.4±3.4 | 46.9±3.2 | 0.460 |
| LVESD (mm) | 26.7±3.5 | 26.4±4 | 0.713 |
| IVS thickness (mm) | 9.7±1.4 | 9.7±1.4 | 0.919 |
| PW thickness (mm) | 9.2±1.0 | 9.2±1.0 | 0.957 |
| LA dimension (mm) | 34.0±3.4 | 34.1 ± 4.6 | 0.894 |
| LVEF (%) | 59.2±4.7 | 59.8±4.6 | 0.490 |
| RV dimesion (mm) | 22.4±2.9 | 21.9±3.5 | 0.466 |
| E (m/sn) | 0.73±0.19 | 0.78±0.18 | 0.211 |
| A (m/sn) | 0.75±0.17 | 0.82±0.19 | 0.076 |
| E/A | 1.03±0.38 | 1.0±0.33 | 0.699 |
| LVMI (gr/m2) | 87.9±16.1 | 85.7±17.8 | 0.245 |
| RWth | 0.37±0.03 | 0.36±0.04 | 0.386 |
IVS – ventrıcular septal thickness; PW – posterior wall thickness; LVEDD – left ventrıcular end-diastolic dimension; LVESD – left ventrıcular end-systolic dimensions; LA – left atrium; LVEF – left ventrıcular ejection fraction; RV – right ventrıcular; E – early diastolic flow; A – atrial contraction signal; LVMI – left ventricular mass index; RWth – relative wall thickness.
The results of exercise testing.
| Variable | MB group (n=50) | Control group (n=48) | P value |
|---|---|---|---|
| METs | 9.6±0.6 | 9.8±0.5 | 0.131 |
| Baseline systolic blood pressure, mm Hg | 126.3±9.1 | 125.9±9.1 | 0.828 |
| Baseline diastolic blood pressure, mm Hg | 73.6±6.6 | 73.3±6.0 | 0.836 |
| Peak systolic blood pressure, mm Hg | 169.7±9.7 | 167.5±7.9 | 0.218 |
| Peak diastolic blood pressure, mm Hg | 83.8±9.9 | 83.1±9.8 | 0.730 |
| Total exercise duration (min) | 8.7±1.1 | 8.8±1.2 | 0.671 |
| % heart rate achieved | 91.5±4.3 | 90.5±4.2 | 0.257 |
METs – metabolic equivalents.
Electrocardiographic repolarization parametres in patients.
| Variable | MB group (n=50) | Control group (n=48) | ||||
|---|---|---|---|---|---|---|
| Baseline | Peak exercise | P value | Baseline | Peak exercise | P value | |
| Heart rate(beats/minute) | 74.3±6.3 | 145.9±11.5 | <0.001 | 72.1±5.4 | 144.6±10.6 | <0.001 |
| QT max (ms) | 372.3±12.1 | 327.8±10.7 | <0.001 | 368.3±11.5 | 304.5±15.1 | <0.001 |
| QT min (ms) | 335.8±14.1 | 285.1±10.5 | <0.001 | 344.9±13.2 | 275.4±14.9 | <0.001 |
| QTd (ms) | 36.4±10.3 | 42.6±14.1 | 0.003 | 27.1±5.4 | 29.1±8.1 | 0.178 |
| cQTd (ms) | 39.3±10.1 | 65.4±16.7 | <0.001 | 28.1±5.5 | 30.1±5.6 | 0.071 |
| Tp-e (ms) | 69±5.7 | 81.1±8.4 | <0.001 | 66.6±7.8 | 65±5.4 | 0.065 |
| cTp-e (ms) | 75.2±6.6 | 94.5±7.4 | <0.001 | 73.2±6.8 | 74.9±8.5 | 0.182 |
| Tp-e/QT | 0.18±0.01 | 0.20±0.02 | <0.001 | 0.18±0.02 | 0.17±0.01 | 0.070 |
QTmax – QT maximum; QTmin – QT minimum; QTd – QT dispersion; cQTd – corrected QT dispersion; Tp-e – transmural dispersion of repolarization; cTp-e – corrected transmural dispersion of repolarization.
Figure 2Comparison of cTp-e interval and Tp-e/QT ratio at baseline and peak exercise in study groups.
Multivariate logistic regression analysis to demonstrate independent predictors of prolonged cTp-e interval.
| Variables | β coefficient | SE | OR (95%CI) | p |
|---|---|---|---|---|
| Age | 0.125 | 0.043 | 0.071 (−0.017–0.159) | 0.110 |
| Length of MB (mm) | 0.446 | 0.148 | 0.797 (0.498–1.096) | |
| Percentage of diameter reduction (%) | 0.510 | 0.059 | 0.343 (0.223–0.462) | |
| LVMI (gr/m2) | −0.109 | 0.026 | −0.041 (−0.093–0.012) | 0.128 |
MB – myocardial bridge; LVMI – left ventricular mass index.